BUFFALO, NY- May 19, 2023 – A new research perspective was published in Oncotarg...
From humans to plants to single-cell organisms, there’s a protein that rules the...
LA JOLLA, CA, May 19, 2023 — Researchers from University of California San Diego...
CHICAGO—May 19, 2023—Blockchain technology, investor sentiment, and economic str...
ARLINGTON, Va.—For Dr. Brett Seidle — the deputy assistant secretary of the Navy...
Scientists are to deploy a network of microphones in the Amazon rainforest to li...
UniQure made an announcement that it has sold a portion of the royalties worth $...
MTBVAC is the only live, attenuated mycobacterium TB vaccine in the pipeline.
The use of digital technology, such as apps, wearables and eConsent, has revolut...
The resubmitted NDA is based on a comprehensive development programme that inclu...
LPX-TI641 is being developed to treat neuro-autoimmune indications including mul...
The combined company will be named enGene Holdings on completion of the deal.
LMN-201 is given concomitantly with standard antibiotics and eight weeks thereaf...
Rivoceranib is an oral TKI, while camrelizumab is a PD-1 inhibitor.
Leaders must renew their commitment to eradicating NTDs if they are to achieve t...
Whilst medicine shortages are a global health problem, European countries are be...
